Episode 10: A View On Manufacturing Hard-to-manufacture Molecules

AI, Digitalization, and Advanced Synthesis in Pharma Manufacturing

In this episode, we speak with François Ricard, Christian Seufert, and Jan Vertommen from Lonza’s Advanced Synthesis platform about how AI-driven process innovation is shaping the development and manufacture of complex molecules.

Tune in to hear how pharmaceutical manufacturing is moving toward more data-driven approaches. From AI-based route scouting to process optimization, our guests discuss how these tools are being applied in practice to improve decision-making and reduce uncertainty in early-stage processes.

They also explore advances in conjugation and bioavailability enhancement, including how new approaches can help identify likely solid-state forms. Together, these innovations support the development and manufacture of increasingly complex, difficult-to-make molecules.